Motus GI Holdings, Inc. (MOTS)

NASDAQ: MOTS · IEX Real-Time Price · USD
-0.28 (-6.54%)
Nov 27, 2023, 4:00 PM EST - Market closed

Company Description

Motus GI Holdings, Inc. operates as a medical technology company in the United States.

It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures.

The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016.

Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.

Motus GI Holdings, Inc.
Motus GI Holdings logo
Country United States
IPO Date Feb 14, 2018
Industry Medical Devices
Sector Healthcare
Employees 43
CEO Mark Pomeranz

Contact Details

1301 East Broward Boulevard, 3rd Floor
Ft. Lauderdale, Florida 33301
United States
Phone 786-459-1831

Stock Details

Ticker Symbol MOTS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001686850
CUSIP Number 62014P108
ISIN Number US62014P5044
Employer ID 81-4042793
SIC Code 3841

Key Executives

Name Position
Timothy P. Moran Chief Executive Officer and Director
Mark Pomeranz President, Chief Operating Officer and Director
Andrew Lawrence Taylor M.B.A. Chief Financial Officer
Scott C. Aldrich Jr. Vice President of Global Marketing and Strategy

Latest SEC Filings

Date Type Title
Nov 27, 2023 8-K Current Report
Nov 13, 2023 10-Q Quarterly Report
Nov 13, 2023 8-K Current Report
Nov 2, 2023 8-K Current Report
Oct 20, 2023 S-1 General form for registration of securities under the Securities Act of 1933
Oct 2, 2023 8-K Current Report
Sep 22, 2023 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 21, 2023 8-K Current Report
Sep 14, 2023 8-K Current Report
Sep 7, 2023 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material